What is Aeovian Pharmaceuticals worth?
$172.0Mlast known valuation
Aeovian Pharmaceuticals last raised $55.0M in its Later Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Aeovian Pharmaceuticals
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC | $55.0M | ▮ | ▮ |
| Dec 2023 | Later Stage VC | $50.4M | ▮ | ▮ |
| Sep 2019 | Early Stage VC | $18.8M | ▮ | ▮ |
How Aeovian Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aeovian Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Aeovian Pharmaceuticals worth?
- Aeovian Pharmaceuticals's last known valuation is $172.0M.
- How much has Aeovian Pharmaceuticals raised?
- Aeovian Pharmaceuticals has raised $143.2M in total funding across 3 recorded rounds.
- When did Aeovian Pharmaceuticals last raise?
- Aeovian Pharmaceuticals last raised in Nov 2025 (Later Stage VC), raising $55.0M.